Joseph James Udoh

Global markets are recalibrating as geopolitical tensions ease in the Middle East while investors grapple with renewed concerns surrounding technology valuations, banking resilience, inflation pressures, and economic growth.

A Harvard Medical School study found advanced AI systems outperformed doctors in emergency room diagnoses under controlled testing. Researchers say AI could become a powerful decision-support tool, improving diagnostic accuracy while complementing, not replacing human clinicians.

Osun State and UNICEF are advancing digital learning and AI solutions to reduce the number of out-of-school children. Through collaboration, innovation and skills development, stakeholders aim to create inclusive education opportunities that prepare every child for a brighter digital future

Ahead of NGO Summit 2026, refugee reporter Godefroy shares his work in safety education and youth empowerment from Kalobeyei. As a community leader and LMTD board member, he brings a voice of lived experience to the global stage.

SpaceX's stock market debut has reportedly propelled Elon Musk beyond the $1 trillion net worth milestone while valuing the company above $2 trillion. The historic IPO highlights investor confidence in space technology, Starlink, and the future of commercial space exploration.

SpaceX is expected to debut on Nasdaq on June 12 under ticker SPCX, giving Nigerian investors a chance to own shares in one of the world's most valuable companies. While the opportunity is historic, analysts warn that a high valuation and expected volatility make caution essential.

Artificial intelligence is revolutionising genomics by speeding up genetic analysis, enabling precision medicine, improving drug discovery, and supporting large-scale health research. AI is helping deliver earlier diagnoses, more effective treatments, and better healthcare outcomes worldwide.

Researchers at the University of Cambridge and DIOSynVax have developed an AI-powered vaccine platform designed to protect against entire virus families. Early trial results show strong safety and immune responses, raising hopes for broader disease prevention and pandemic preparedness.